US Patent Issued to Immatics Biotechnologies on March 11 for "Peptides displayed by HLA for use in immunotherapy against different types of cancers" (German, American Inventors)

ALEXANDRIA, Va., March 12 -- United States Patent no. 12,246,039, issued on March 11, was assigned to Immatics Biotechnologies GmbH (Tubingen, Germany).

"Peptides displayed by HLA for use in immunotherapy against different types of cancers" was invented by Ricarda Hannen (Tuebingen, Germany), Jens Hukelmann (Tuebingen, Germany), Florian Koehler (Tuebingen, Germany), Daniel Johannes Kowalewski (Tuebingen, Germany), Heiko Schuster (Tuebingen, Germany), Oliver Schoor (Tuebingen, Germany), Michael Roemer (Tuebingen, Germany), Chih-Chiang Tsou (Houston) and Jens Fritsche (Tuebingen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a peptide comprising an amino acid sequence selected...